Pfizer's new trial vaccine for RSV is over 85% effective in older adults
August 25, 2022 at 14:13 PM EDT
Pfizer announced on Thursday that a vaccine designed to stop respiratory syncytial virus, or RSV, infections is over 85% effective in older adults.
